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Lepidic predominant adenocarcinoma (LPA) (formerly known as bronchioalveolar carcinoma) has rarely
been reported to cause refractory hypoxia with intrapulmonary shunting [1e7]. We describe a case who
underwent the palliative strategy of intravascular right lower pulmonary artery embolisation with an
18 mm Amplatzer II vascular plug to reduce intrapulmonary shunting. This is the ﬁrst report we are
aware of using this minimally invasive procedure to treat this condition.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Clinical record for further invasive investigations such as biopsy, or treatment suchA 64 year old man presented with haemoptysis and refractory
hypoxia (p02 41 mmHg on FiO2 0.8) following a short airﬂight. He
was transferred for palliation closer to home. His history included
50 pack years smoking, asbestos exposure and weight loss. CT
thorax (See Fig. 1) revealed extensive, dense consolidation of both
lungs, bilateral hilar and subcarinal adenopathy, and centrilobular
emphysema, but with no distant metastases evident. Sputum
cytology reported atypical cells, favouring adenocarcinoma. He was
polycythaemic with a haemoglobin of 203 g/L. He received antibi-
otics to treat any infective component, and glucocorticoids but
without signiﬁcant improvement. His oxygen saturations remained
between 70 and 80% despite high ﬂow oxygen. He was too unwellnocarcinoma; CT, computed
y Group performance status;
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Ltd. This is an open access article uas chemotherapy (unknown ALK and EGFR status). He sought
palliation and was discharged home with home oxygen approxi-
mately 10 L/min achieved via OxyMask with 2 connected oxygen
concentrators.
8 months after initial diagnosis, he remained hypoxic, although
his general condition remained stable (ECOG performance status 3)
with no evidence of other end organ dysfunction. He was re-
evaluated with CT scans, respiratory function tests, arterial blood
gases, VQ scan, bubble contrast echocardiogram and a 100% oxygen
shunt study. The calculated shunt fraction was 25% (p02 54.1 on
100% O2, PCO2 38.9, SaO2 88%. Hb195) There was no evidence of
extra-pulmonary shunting. The VQ scan revealed marked perfusion
to the unventilated right lower lobe, consistent with signiﬁcant
intrapulmonary shunting. Distant metastases were not detected
and there was only marginal progression of his extensive consoli-
dation to both lungs. Given his poor pulmonary reserve, biopsy for
EGFR and ALK status was not undertaken. However after multi-
disciplinary discussion, the feasibility of a palliative procedure to
reduce the shunt and hopefully improve his oxygenation and
quality of life was considered.
With informed consent, he underwent pulmonary angiography
with intrapulmonary catheterisation and temporary occlusion of
the right inferior pulmonary artery which improved oxygennder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lower lobe pulmonary artery with an 18 mm Amplatzer vascular
plug II device was then performed. (See Fig. 2) He improved clini-
cally although the dramatic improvement in oxygenation was not
sustained with SaO2 decreasing to 78e81% on 10 L O2 within 1 day.
Repeat VQ scanning 3 days later conﬁrmed reduced perfusion of
the non-ventilated posterobasal and lateral basal segments of the
right lower lobe compared with the pre-procedural scan. However
there was still ﬂow to the superior and anterobasal segments of the
right lower lobe. (See Fig. 3). He remained stable and was dis-
charged home 5 days post procedure. He reported marked symp-
tomatic improvement in his ability to carry out activities of daily
living. His home monitored peripheral SaO2 were between 71 and
96 % with a median of 86%. He subsequently died 3 months later
from a complicated pneumothorax and pulmonary embolism.
Autopsy revealed extensive LPA involving all lobes of both lungs
as well as hilar, mediastinal and retrosternal lymph nodes. There
was a right upper lobe pulmonary embolus and a left upper lobe
abscess colonised by aspergillus. The Amplatzer vascular plug was
identiﬁed within a large vessel at the boundary of the right lower
and middle lobes, with no evidence it contributed to his death.2. Discussion
This is the ﬁrst report we are aware of to use this minimally
invasive, palliative procedure to improve shunting within a lung
adenocarcinoma (lepidic predominant). There are few literature
reports of LPA with refractory hypoxia from intrapulmonary
shunting [1e7]. 5 reports have described 10 patients whoFig. 1. a) CT coronal view, b) CT axial view.underwent palliative surgery to correct the intrapulmonary shunt
and hypoxia (see Table 1) [1e5] Survival post resection ranged from
21 days to 24 months [1e5]. Some underwent chemotherapy and/
or radiation therapy [1e5]. One patient even proceeded toFig. 2. a) Pre vascular plug, b) vascular plug proﬁle, c) post.
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also been reported in squamous cell carcinoma and carcinoid of the
lung [8e11].
It is uncertain why our patient's initial dramatic oxygenation
improvement was not sustained. Imaging did not reveal signiﬁcant
movement of the Amplatzer plug. Perhaps with his extensive
bilateral lung disease, the moderate perfusion correction to un-
ventilated lung was not enough to clearly demonstrate pO2Fig. 3. VQ scan a) before aimprovement. Despite no sustained improvement in oxygen satu-
ration, he felt better and was more able to perform his activities of
daily living. Unfortunately formal assessments of quality of life
were not undertaken before and after the intervention.
The total cost of the Amplatzer II vascular plug and associated
procedural costs is estimated at $1500, and bed costs approxi-
mately $2000. His home oxygen usage was unchanged but the
palliative beneﬁts of improving quality of life must not bend b) after procedure.
Table 1
Published cases of intrapulmonary shunting from lung cancer causing refractory hypoxia.
Authors Age (years)
Sex
Cancer ECOG Initial PO2
(mmHg)
P02 after surgery Treatment Survival
Barlesi et al. [1] 2001 53 M LPA 1 54 on 5L02 133 on 5L02 Surgery þ Chemo 3 months
54 F LPA 1 53 on 5L02 125 on 5L 02 Surgery þ Chemo 12 months
68 M LPA 2 46 on 5L02 102 on 5L02 Surgery 21 days MI complicating pneumonia
46 M LPA 2 49 on 5L 02 240 on 5L 02 Surgery þ chemo 18 months
(7 other cases at institution) (survival 1e11 months. Mean 6.4 months)
From respiratory failure
Chetty et al. [2] 1997 71 M LPA 46 on RA 63 on RA Surgery þ XRT 6 months from stroke
Falcoz et al. [3] 2009 68 M LPA 45 on RA 72 on RA Surgery þ Chemo 24 months
54 M LPA 57 on RA 75 on RA Surgery þ subsequent
Lung transplant
16 months later, post op after lung
transplantation due to colon perforation
63 M LPA 55 on 15L 02 109 on RA Neoadjuvant chemo
then surgery
Alive 6 months after surgery
Fishman et al. [4] 1974 64 M LPA 21 on RA 55 to 68 on RA Surgery 8 months
Sarlin et al. [5] 1980 68 M LPA 58 on RA 80 on RA Surgery Alive 7 months later
Vanoyan et al. [6] 1998 LPA
Venkata et al. [7] 2009 74 M LPA 49 on 2L02 and
52 on 100%O2
Ventilator support withdrawn after
30 days
Wartski et al. [8] 1998 68 M SCC 47 on RA
84.7 on 100%O2
79.5 on RA XRT Alive 1 year later
Kikano et al. [9] 1994 ? Proximal
bronchial
cancer
52 Surgery
Hussain et al. [10] 1994 36 M Carcinoid 6.14 kPa on RA
(46 mmHg)
Chemo Alive 1 year later
Lee et al. [11] 1999 37 F carcinoid 46 on RA
71 on 100%O2
M ¼male, F ¼ female, LPA ¼ lepidic predominant adenocarcinoma (formerly known as bronchioalveolar adenocarcinoma), SCC ¼ squamous cell carcinoma. ECOG ¼ Eastern
Cooperative Oncology Group Performance Status, RA ¼ room air, O2 ¼ oxygen, Chemo ¼ chemotherapy, XRT ¼ radiation therapy, MI ¼ myocardial infarction.
J.Y.-A. Tan et al. / Respiratory Medicine Case Reports 15 (2015) 121e124124discounted. Compared with major palliative thoracic surgical
resection, intravascular stenting is less invasive and should be
associated with shorter hospital stays.
Although life expectancy is unlikely to change, this procedure
may also have a role as bridging therapy while awaiting more
deﬁnitive treatment for selected cases with minimal disease.
3. Conclusion
This is a novel, minimally invasive approach to lung adenocar-
cinoma with lepidic pattern with refractory hypoxia from intra-
pulmonary shunting for symptom relief. Given the rarity of this
condition, further studies with multi-centre collaboration are
needed.
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